PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32306410-1	2020	BACKGROUND: Hematopoietic cell infusion-related adverse events (HCI-AEs) in hematopoietic stem cell transplantations (HSCTs) have been largely attributed to toxicity of dimethyl sulfoxide (DMSO) for cryopreservation, but HSC products also contain various cells and plasma components.	Dimethyl Sulfoxide	169-187	fucosyltransferase 1 (H blood group)	Homo sapiens	118-121	
32306410-1	2020	BACKGROUND: Hematopoietic cell infusion-related adverse events (HCI-AEs) in hematopoietic stem cell transplantations (HSCTs) have been largely attributed to toxicity of dimethyl sulfoxide (DMSO) for cryopreservation, but HSC products also contain various cells and plasma components.	Dimethyl Sulfoxide	189-193	fucosyltransferase 1 (H blood group)	Homo sapiens	118-121	
18161920-11	2007	These results suggested that a moderate dosage had the most obvious inhibitory efficacy at 48 h. Compared to the DMSO group, the mitosis index of the LSC, MSC, HSC groups was greatly decreased (P < 0.05) at all time points.	Dimethyl Sulfoxide	113-117	fucosyltransferase 1 (H blood group)	Homo sapiens	160-163